Quick Facts
Corporate HQ:	New York, NY
Employer Home Page:	www.sanofi-synthelabous.com/
Employer Careers Page:	www.sanofi-synthelabous.com/career/in...

View all Sanofi-Synthelabo Inc. jobs on BostonWorks.com

Company Description:

We are Sanofi-Synthelabo Inc., the U.S. subsidiary of Sanofi-Synthelabo, the global pharmaceutical company.

With 2002 annual sales in excess of $8.4 billion and 33,000 employees in more than 100 countries, Sanofi-Synthelabo ranks among the world's top 20 pharmaceutical companies and the top seven pharmaceutical companies in Europe. World headquarters are in Paris, France; U.S. headquarters are in New York City. For more information on our parent, Sanofi-Synthelabo, click here.

In the U.S., as it is in other major markets, Sanofi-Synthelabo's principle area of business is ethical pharmaceuticals. Our core therapeutic areas are cardiovascular disease and thrombosis; diseases of the central nervous system; oncology and internal medicine.

In the U.S., Sanofi-Synthelabo Inc. markets Ambien®, (zolpidem tartrate); Arixtra® (fondaparinux sodium); Avapro® (irbesartan); Eligard™ (leuprolide acetate for injectable suspension); Elitek™ (rasburicase); Hyalgan® (sodium hyaluronate); Eloxatin™ (oxaliplatin for injection); and Plavix® (clopidogrel bisulfate), among other products.

The foundation of Sanofi-Synthelabo's worldwide growth is a highly regarded Research and Development (R&D) program. Today, we currently have 52 compounds under development, of which 23 are in Phase II and Phase III.

Products from the R&D program of Sanofi-Synthelabo generate more than $3 billion in annual sales in the U.S.

In the U.S., Sanofi-Synthelabo has career opportunities at our commercial headquarters in New York City, our pharmaceutical Research and Development headquarters in Malvern, Pennsylvania, and on our Field Sales team throughout the country.

Click here to apply online for our current positions.

Sanofi-Synthelabo's U.S. unit is an equal employment opportunity employer and a Federal contractor.